Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient versus inpatient mifepristone for cervical ripening before labor induction
ISRCTN26164110Phase 4Completed
- Sponsor
- Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mifepristone in induced labor and unfavorable cervix (2 arms), sponsored by Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology. Primary endpoints: Bishop score after mifepristone administration, Additional cervical ripening methods and 3 more. Started Feb 2020; status: completed.
02
Drugs
mifepristone
03
Conditions
induced laborunfavorable cervix
Beyond the preview
Go deeper on ISRCTN26164110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26164110.